{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "4636ca11",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "28dbb05a",
   "metadata": {},
   "outputs": [],
   "source": [
    "text = [\n",
    "'antitumorpromot principl angelica keiskei potent antitumor promot activ nonpolar extract root ashitaba angelica keiskei koidz umbellifera eaten veget japan activ fraction angular furanocoumarin archangelicin sr angeloyloxydihydrooroselol linear furanocoumarin psoralen bergapten xanthotoxin chalcon hydroxyderricin xanthoangelol novel chalcon name ashitabachalcon isol compound angular type furanocoumarin chalcon suppress otetradecanoylphorbolacet tpa piincorpor phospholipid cultur cell coumarin less effect addit chalcon prove antitumorpromot activ mous skin carcinogenesi induc dimethylbenz anthracen dmba plus tpa chalcon calmodulininteract properti chalcon reveal antitumorpromot activ via modul calmodulin involv system chalcon effect prevent'\n",
    "'effect catechin mous lung carcinoma cell adhes endotheli cell effect kind catechin adhes mous lung carcinoma ll cell monolay bovin lung endotheli cell epicatechin gallat epigallocatechingal activ inhibit ll cell adhes catechin epicatechin inact epigallocatechin consider cytotox specif structur requir exert inhibitori activ catechin search cellular bind protein bound inhibitori catechin clue clarifi mechan interact cell endotheli cell'\n",
    "'cyclooxygenas inhibitor potenti properti colon epidemiolog laboratori indic invers risk colon intak nonsteroid antiinflammatori agent aspirin mechan nonsteroid antiinflammatori agent inhibit colon inhibit prostaglandin cyclooxygenas isozym cox cox overexpress cox colon inhibitor cox potenti serv agent properti sc cox inhibitor sulindac control doubleblind azoxymethan induc colon aberr crypt foci acf measur efficaci fiveweekold male fed control modifi aina ppm sc ppm sulindac ppm placebo later anim except vehicl normal salin sc inject azoxymethan bodi onc age sacrif colon acf expect sulindac suppress acf crypt term aberr crypt focus ppm sc inhibit total acf crypt sc suppress colon acf format crypt strengthen hypothesi cox inhibitor possess activ against colon '\n",
    "'phase novel sulfonamid discov slowgrow colon carcinoma cell screen model exhibit broad spectrum antitumor activ against human xenograft mechan action arrest cell phase cell cycl inhibit tubulin polymer object phase maximum allow dose mad pharmacokinet singl repeat dose singledos administ oral patient dose doselimit peripher neuropathi dose hematolog gastrointestin mild repeateddos patient dose per doselimit peripher neuropathi intestin paralysi gastrointestin dosedepend not sever hematolog not dosedepend pharmacokinet singledos rapid plasma level after disappear variat area plasma concentrationtim curv auc patient dosedepend manner total recoveri urin after indic favor absorpt elimin profil chang plasma level repeateddos indic did not accumul singledos spinal cord metastasi exhibit reduct patient uterin sarcoma minor mr pulmonari adenocarcinoma patient repeateddos decreas carcinoembryon antigen cea squamous cell carcinoma antigen scc patient stomach patient recurr uterin cervic carcinoma recommend phase ii dose singledos per repeateddos activ timedepend ie certain requir suppress growth leukemia cell recommend phase ii conduct dose schedul maintain blood level e'\n",
    "'retinoid iv design synthesi structureact ditbutylphenyl compound retino analogu play role modul cell growth differenti apoptosi clinic moieti ditbutylhydroxi phenyl ring seri substitut amid ester chalcon design synthes mimic molecular shape size spacial disposit retino general structur formula see text where stand hydrogen atom methyl linkag conh nhco coo coch ch member heterocycl substitu differ sar indic presenc hydrophob end molecul carboxyl end conjug system molecul necessari full prerequisit exhibit activ loss abolish activ obligatori antioxid effect hydroxi not convey biolog activ after methyl hydroxi compound differentiationinduc activ lose antioxid effect indic correl activ stabl conform phenyl ring cisconform nmethyl acyl amid featur bent shape molecul instead extend conform taken nonnmethyl partner alltran retino bent conform account inact paper compound exhibit signific activ ditmethoxyphenyl oxopropenyl benzoic activ compar retino pharmacolog action '\n",
    "'elicit pleiotrop molecular effect head neck cell trihydroxyisoflavon report induc cell cycl arrest apoptosi differ cell line vitro antitumor activ against varieti anim model report induc cell cycl arrest apoptosi upregul pwaf bax downregul cyclin bcl head neck cell line precis molecular mechan elicit effect head neck cell still elucid report induc specif molecular chang head neck cell downregul cerbb express downregul mmp mmp secret inhibit cell invas downregul nuclear factorkappab bind activ addit inhibit level phosphoryl akt express protein moreov induc telomer shorten cell telomeras activ vitro inhibit transloc telomeras catalyt subunit human telomeras revers transcriptas htert nucleus result telomer shorten activ telomeras unaffect inhibit metaphas spread chromosom result togeth publish report conclud elicit pleiotrop molecular chang result inhibit cell growth apoptot cell death head neck cell chemotherapeut agent head neck '\n",
    "'mechanismbas vitro screen potenti agent identif effect agent becom issu public healthrel research identif potenti constitu set up batteri cell enzymebas vitro system relev prevent carcinogenesi vivo system modul inhibit cypa activ nadphquinon reductas qr activ hepacc murin hepatoma cell cultur scaveng dpph scaveng antioxid effect scaveng superoxid anion hydroxyl peroxylrad antiinflammatori mechan inhibit lipopolysaccharid lps mediat nitric generat induc synthas ino raw murin macrophag cyclooxygenas cox inhibit antitumor promot activ inhibit phorbol ester induc ornithin decarboxylas odc activ murin keratinocyt test seri known belong structur compound identif novel agent mechan organosulfur compound phenethylisothiocyan peitc diallylsulfid diallyldisulfid terpen limonen perillyl alcohol oleanol betaglycyrrhetin shortchain fatti sodium butyr indol indolecarbinol quercetin silymarin catechin epigallocatechingal egcg simpl ellag piceatannol curcumin pharmaceut agent piroxicam acetylsalicyl tamoxifen deriv ascorb trolox confirm known mechan compound addit demonstr approach identif hitherto unknown mechan agent exampl detect antiinflammatori properti peitc nfkappabmedi inhibit peitc inhibit phorbol ester induc superoxid anion granulocyt odc cell line mechan contribut potenti peitc'\n",
    "'epigallocatechingal inhibit activ her neu downstream signal pathway human head neck breast carcinoma cell overexpress her neu receptor her associ poor prognosi patient breast carcinoma patient head neck squamous cell carcinoma hnscc hnscc cell line epigalocathechingal egcg biolog activ compon green tea inhibit activ epiderm growth receptor egfr therebi inhibit egfrrel downstream signal pathway hnscc cell effect egcg activ her receptor human hnscc breast carcinoma cell line display constitut activ her cell microg egcg dose inhibit growth mark inhibit phosphoryl her cell line associ inhibit stat activ inhibit cfos cyclin promot activ decreas cellular level cyclin bclxl protein egcg microg plasma after administ singl oral dose egcg green tea extract mark enhanc sensit type cell line growth inhibit taxol frequent breast carcinoma hnscc result taken togeth evid egcg inhibit activ egfr carcinoma cell egcg case breast carcinoma hnscc activ egfr her play role surviv growth'\n",
    "'xenoestrogen induc erk erk activ via membraneiniti signal pathway xenoestrogen mimic antagon activ physiolog estrogen mechan xenoestrogen action involv bind esr er failur vitro vivo assay strong genom activ xenoestrogen compar estradiol make difficult explain abil abnorm anim human reproduct via pathway steroid action rapid intracellular signal chang level intracellular calcium camp nitric activ varieti kinas via action membran demonstr xenoestrogen rapid activ extracellularregul kinas erk pituitari cell line gh express level membran receptor esr mer test phytoestrogen coumestrol organochlorin pesticid endosulfan dieldrin dde deterg byproduct plastic manufactur pnonylphenol bisphenol xenoestrogen except bisphenola produc rapid min after applic depend erk phosphoryl distinct differ activ pattern signal pathway involv erk activ specif inhibitor er epiderm growth receptor ca signal src phosphoinositid kinas membran structur disrupt agent inhibitor block erk activ simultan pathway complex signal web interact inhibitor differenti xenoestrogen action help explain distinct abil xenoestrogen disrupt reproduct low '\n",
    "'effect empir appl hydrogen peroxid induc inhibit gapjunct intercellular communic antioxid antitumorpromot activ phytochem appl content antioxid empir appl quantifi contribut total antioxid activ appl assay inhibit otetradecanoylphorbolacet induc superoxid generat cell cultur model express equival antioxid capac vceac estim contribut total anitoxid capac fresh empir appl quercetin vceac chlorogen phloretin procyanidin epicatechin superoxid scaveng assay report mechan carcinogen hydrogen peroxid ho associ inhibit gapjunct intercellular communic gjic involv promot appl extract protect effect against inhibit gjic ho dosedepend manner quercetin exert strongest protect effect antioxid appl ho induc inhibit gjic epicatechin procyanidin chlorogen phloretin effect result indic activ appl associ antioxid capac antitumorpromot activ divers antioxid'\n",
    "'lowdos phytoestrogen abrog tamoxifenassoci mammari prevent wildtyp erbb neu transgen mice interact tamoxifen phytoestrogen dose vivo mice random formula implant continuousreleas tamoxifen placebo pellet age placebotr mice soy meal not supplement lowdos highdos casein result prolong latenc tamoxifentr mice fed soy meal casein highdos enrich format age mice latenc prolong tamoxifentr mice fed lowdos enrich much rate mammari shorter latenc vitro human mous mammari cell line confirm low dose coadminist tamoxifen promot cell prolifer tamoxifen alon tamoxifen dose growth inhibitori summari lowdos abrog tamoxifenassoci mammari prevent vivo interact support vitro human mous mammari cell line doseassoci interact like relev human tamoxifen prevent breast '\n",
    "'new anticanc agent vitro vivo antitumor antimetastat action compound isol medicin plant review search new anticanc effect compound isol medicin plant growth metastasi mice bear metastat drugresist mous antitumor antimetastat action stilben deriv isol polygonum cassia stilben deriv cassiagrol stilben dimer display antitumor antimetastat action inhibit induc neovascular vitro vivo model chalcon deriv angelica keiskei root inhibit growth metastasi tumorbear mice inhibit induc neovascular inhibit suppress basidiomycet fungi low molecular isol agaricus blazei ganoderma lucidum antitumor antimetastat basidiomycet inhibit growth metastasi lung inhibit induc neovascular inhibit suppress '\n",
    "'celecoxib revers hypoxia induc angiopoietin upregul gastric potenti effect cyclooxygenas cox hypoxia induc angiopoietin ang express gastric cell result reveal hypoxia augment cox ang express hypoxia induc ang mimick cocl genestein partial counteract hypoxia induc ang express celecoxib not cox inhibitor sc revers hypoxia induc ang express effect partial restor addit exogen pge hypoxiaelev ang express gastric cell mediat coxderiv pge hifalpha pathway celecoxib counteract hypoxia induc ang express']\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "3b96edd1",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['antitumorpromot principl angelica keiskei potent antitumor promot activ nonpolar extract root ashitaba angelica keiskei koidz umbellifera eaten veget japan activ fraction angular furanocoumarin archangelicin sr angeloyloxydihydrooroselol linear furanocoumarin psoralen bergapten xanthotoxin chalcon hydroxyderricin xanthoangelol novel chalcon name ashitabachalcon isol compound angular type furanocoumarin chalcon suppress otetradecanoylphorbolacet tpa piincorpor phospholipid cultur cell coumarin less effect addit chalcon prove antitumorpromot activ mous skin carcinogenesi induc dimethylbenz anthracen dmba plus tpa chalcon calmodulininteract properti chalcon reveal antitumorpromot activ via modul calmodulin involv system chalcon effect preventeffect catechin mous lung carcinoma cell adhes endotheli cell effect kind catechin adhes mous lung carcinoma ll cell monolay bovin lung endotheli cell epicatechin gallat epigallocatechingal activ inhibit ll cell adhes catechin epicatechin inact epigallocatechin consider cytotox specif structur requir exert inhibitori activ catechin search cellular bind protein bound inhibitori catechin clue clarifi mechan interact cell endotheli cellcyclooxygenas inhibitor potenti properti colon epidemiolog laboratori indic invers risk colon intak nonsteroid antiinflammatori agent aspirin mechan nonsteroid antiinflammatori agent inhibit colon inhibit prostaglandin cyclooxygenas isozym cox cox overexpress cox colon inhibitor cox potenti serv agent properti sc cox inhibitor sulindac control doubleblind azoxymethan induc colon aberr crypt foci acf measur efficaci fiveweekold male fed control modifi aina ppm sc ppm sulindac ppm placebo later anim except vehicl normal salin sc inject azoxymethan bodi onc age sacrif colon acf expect sulindac suppress acf crypt term aberr crypt focus ppm sc inhibit total acf crypt sc suppress colon acf format crypt strengthen hypothesi cox inhibitor possess activ against colon phase novel sulfonamid discov slowgrow colon carcinoma cell screen model exhibit broad spectrum antitumor activ against human xenograft mechan action arrest cell phase cell cycl inhibit tubulin polymer object phase maximum allow dose mad pharmacokinet singl repeat dose singledos administ oral patient dose doselimit peripher neuropathi dose hematolog gastrointestin mild repeateddos patient dose per doselimit peripher neuropathi intestin paralysi gastrointestin dosedepend not sever hematolog not dosedepend pharmacokinet singledos rapid plasma level after disappear variat area plasma concentrationtim curv auc patient dosedepend manner total recoveri urin after indic favor absorpt elimin profil chang plasma level repeateddos indic did not accumul singledos spinal cord metastasi exhibit reduct patient uterin sarcoma minor mr pulmonari adenocarcinoma patient repeateddos decreas carcinoembryon antigen cea squamous cell carcinoma antigen scc patient stomach patient recurr uterin cervic carcinoma recommend phase ii dose singledos per repeateddos activ timedepend ie certain requir suppress growth leukemia cell recommend phase ii conduct dose schedul maintain blood level eretinoid iv design synthesi structureact ditbutylphenyl compound retino analogu play role modul cell growth differenti apoptosi clinic moieti ditbutylhydroxi phenyl ring seri substitut amid ester chalcon design synthes mimic molecular shape size spacial disposit retino general structur formula see text where stand hydrogen atom methyl linkag conh nhco coo coch ch member heterocycl substitu differ sar indic presenc hydrophob end molecul carboxyl end conjug system molecul necessari full prerequisit exhibit activ loss abolish activ obligatori antioxid effect hydroxi not convey biolog activ after methyl hydroxi compound differentiationinduc activ lose antioxid effect indic correl activ stabl conform phenyl ring cisconform nmethyl acyl amid featur bent shape molecul instead extend conform taken nonnmethyl partner alltran retino bent conform account inact paper compound exhibit signific activ ditmethoxyphenyl oxopropenyl benzoic activ compar retino pharmacolog action elicit pleiotrop molecular effect head neck cell trihydroxyisoflavon report induc cell cycl arrest apoptosi differ cell line vitro antitumor activ against varieti anim model report induc cell cycl arrest apoptosi upregul pwaf bax downregul cyclin bcl head neck cell line precis molecular mechan elicit effect head neck cell still elucid report induc specif molecular chang head neck cell downregul cerbb express downregul mmp mmp secret inhibit cell invas downregul nuclear factorkappab bind activ addit inhibit level phosphoryl akt express protein moreov induc telomer shorten cell telomeras activ vitro inhibit transloc telomeras catalyt subunit human telomeras revers transcriptas htert nucleus result telomer shorten activ telomeras unaffect inhibit metaphas spread chromosom result togeth publish report conclud elicit pleiotrop molecular chang result inhibit cell growth apoptot cell death head neck cell chemotherapeut agent head neck mechanismbas vitro screen potenti agent identif effect agent becom issu public healthrel research identif potenti constitu set up batteri cell enzymebas vitro system relev prevent carcinogenesi vivo system modul inhibit cypa activ nadphquinon reductas qr activ hepacc murin hepatoma cell cultur scaveng dpph scaveng antioxid effect scaveng superoxid anion hydroxyl peroxylrad antiinflammatori mechan inhibit lipopolysaccharid lps mediat nitric generat induc synthas ino raw murin macrophag cyclooxygenas cox inhibit antitumor promot activ inhibit phorbol ester induc ornithin decarboxylas odc activ murin keratinocyt test seri known belong structur compound identif novel agent mechan organosulfur compound phenethylisothiocyan peitc diallylsulfid diallyldisulfid terpen limonen perillyl alcohol oleanol betaglycyrrhetin shortchain fatti sodium butyr indol indolecarbinol quercetin silymarin catechin epigallocatechingal egcg simpl ellag piceatannol curcumin pharmaceut agent piroxicam acetylsalicyl tamoxifen deriv ascorb trolox confirm known mechan compound addit demonstr approach identif hitherto unknown mechan agent exampl detect antiinflammatori properti peitc nfkappabmedi inhibit peitc inhibit phorbol ester induc superoxid anion granulocyt odc cell line mechan contribut potenti peitcepigallocatechingal inhibit activ her neu downstream signal pathway human head neck breast carcinoma cell overexpress her neu receptor her associ poor prognosi patient breast carcinoma patient head neck squamous cell carcinoma hnscc hnscc cell line epigalocathechingal egcg biolog activ compon green tea inhibit activ epiderm growth receptor egfr therebi inhibit egfrrel downstream signal pathway hnscc cell effect egcg activ her receptor human hnscc breast carcinoma cell line display constitut activ her cell microg egcg dose inhibit growth mark inhibit phosphoryl her cell line associ inhibit stat activ inhibit cfos cyclin promot activ decreas cellular level cyclin bclxl protein egcg microg plasma after administ singl oral dose egcg green tea extract mark enhanc sensit type cell line growth inhibit taxol frequent breast carcinoma hnscc result taken togeth evid egcg inhibit activ egfr carcinoma cell egcg case breast carcinoma hnscc activ egfr her play role surviv growthxenoestrogen induc erk erk activ via membraneiniti signal pathway xenoestrogen mimic antagon activ physiolog estrogen mechan xenoestrogen action involv bind esr er failur vitro vivo assay strong genom activ xenoestrogen compar estradiol make difficult explain abil abnorm anim human reproduct via pathway steroid action rapid intracellular signal chang level intracellular calcium camp nitric activ varieti kinas via action membran demonstr xenoestrogen rapid activ extracellularregul kinas erk pituitari cell line gh express level membran receptor esr mer test phytoestrogen coumestrol organochlorin pesticid endosulfan dieldrin dde deterg byproduct plastic manufactur pnonylphenol bisphenol xenoestrogen except bisphenola produc rapid min after applic depend erk phosphoryl distinct differ activ pattern signal pathway involv erk activ specif inhibitor er epiderm growth receptor ca signal src phosphoinositid kinas membran structur disrupt agent inhibitor block erk activ simultan pathway complex signal web interact inhibitor differenti xenoestrogen action help explain distinct abil xenoestrogen disrupt reproduct low effect empir appl hydrogen peroxid induc inhibit gapjunct intercellular communic antioxid antitumorpromot activ phytochem appl content antioxid empir appl quantifi contribut total antioxid activ appl assay inhibit otetradecanoylphorbolacet induc superoxid generat cell cultur model express equival antioxid capac vceac estim contribut total anitoxid capac fresh empir appl quercetin vceac chlorogen phloretin procyanidin epicatechin superoxid scaveng assay report mechan carcinogen hydrogen peroxid ho associ inhibit gapjunct intercellular communic gjic involv promot appl extract protect effect against inhibit gjic ho dosedepend manner quercetin exert strongest protect effect antioxid appl ho induc inhibit gjic epicatechin procyanidin chlorogen phloretin effect result indic activ appl associ antioxid capac antitumorpromot activ divers antioxidlowdos phytoestrogen abrog tamoxifenassoci mammari prevent wildtyp erbb neu transgen mice interact tamoxifen phytoestrogen dose vivo mice random formula implant continuousreleas tamoxifen placebo pellet age placebotr mice soy meal not supplement lowdos highdos casein result prolong latenc tamoxifentr mice fed soy meal casein highdos enrich format age mice latenc prolong tamoxifentr mice fed lowdos enrich much rate mammari shorter latenc vitro human mous mammari cell line confirm low dose coadminist tamoxifen promot cell prolifer tamoxifen alon tamoxifen dose growth inhibitori summari lowdos abrog tamoxifenassoci mammari prevent vivo interact support vitro human mous mammari cell line doseassoci interact like relev human tamoxifen prevent breast new anticanc agent vitro vivo antitumor antimetastat action compound isol medicin plant review search new anticanc effect compound isol medicin plant growth metastasi mice bear metastat drugresist mous antitumor antimetastat action stilben deriv isol polygonum cassia stilben deriv cassiagrol stilben dimer display antitumor antimetastat action inhibit induc neovascular vitro vivo model chalcon deriv angelica keiskei root inhibit growth metastasi tumorbear mice inhibit induc neovascular inhibit suppress basidiomycet fungi low molecular isol agaricus blazei ganoderma lucidum antitumor antimetastat basidiomycet inhibit growth metastasi lung inhibit induc neovascular inhibit suppress celecoxib revers hypoxia induc angiopoietin upregul gastric potenti effect cyclooxygenas cox hypoxia induc angiopoietin ang express gastric cell result reveal hypoxia augment cox ang express hypoxia induc ang mimick cocl genestein partial counteract hypoxia induc ang express celecoxib not cox inhibitor sc revers hypoxia induc ang express effect partial restor addit exogen pge hypoxiaelev ang express gastric cell mediat coxderiv pge hifalpha pathway celecoxib counteract hypoxia induc ang express']"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "84e23aef",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'antitumorpromot': 47,\n",
       " 'principl': 495,\n",
       " 'angelica': 31,\n",
       " 'keiskei': 337,\n",
       " 'potent': 487,\n",
       " 'antitumor': 46,\n",
       " 'promot': 502,\n",
       " 'activ': 11,\n",
       " 'nonpolar': 420,\n",
       " 'extract': 253,\n",
       " 'root': 542,\n",
       " 'ashitaba': 57,\n",
       " 'koidz': 342,\n",
       " 'umbellifera': 636,\n",
       " 'eaten': 209,\n",
       " 'veget': 646,\n",
       " 'japan': 336,\n",
       " 'fraction': 265,\n",
       " 'angular': 34,\n",
       " 'furanocoumarin': 270,\n",
       " 'archangelicin': 53,\n",
       " 'sr': 582,\n",
       " 'angeloyloxydihydrooroselol': 32,\n",
       " 'linear': 352,\n",
       " 'psoralen': 508,\n",
       " 'bergapten': 76,\n",
       " 'xanthotoxin': 655,\n",
       " 'chalcon': 119,\n",
       " 'hydroxyderricin': 304,\n",
       " 'xanthoangelol': 654,\n",
       " 'novel': 424,\n",
       " 'name': 408,\n",
       " 'ashitabachalcon': 58,\n",
       " 'isol': 332,\n",
       " 'compound': 136,\n",
       " 'type': 635,\n",
       " 'suppress': 605,\n",
       " 'otetradecanoylphorbolacet': 436,\n",
       " 'tpa': 627,\n",
       " 'piincorpor': 471,\n",
       " 'phospholipid': 465,\n",
       " 'cultur': 161,\n",
       " 'cell': 111,\n",
       " 'coumarin': 155,\n",
       " 'less': 346,\n",
       " 'effect': 210,\n",
       " 'addit': 13,\n",
       " 'prove': 507,\n",
       " 'mous': 403,\n",
       " 'skin': 572,\n",
       " 'carcinogenesi': 101,\n",
       " 'induc': 317,\n",
       " 'dimethylbenz': 188,\n",
       " 'anthracen': 39,\n",
       " 'dmba': 199,\n",
       " 'plus': 481,\n",
       " 'calmodulininteract': 95,\n",
       " 'properti': 503,\n",
       " 'reveal': 536,\n",
       " 'via': 648,\n",
       " 'modul': 397,\n",
       " 'calmodulin': 94,\n",
       " 'involv': 331,\n",
       " 'system': 610,\n",
       " 'preventeffect': 494,\n",
       " 'catechin': 108,\n",
       " 'lung': 362,\n",
       " 'carcinoma': 102,\n",
       " 'adhes': 15,\n",
       " 'endotheli': 222,\n",
       " 'kind': 340,\n",
       " 'll': 355,\n",
       " 'monolay': 401,\n",
       " 'bovin': 87,\n",
       " 'epicatechin': 226,\n",
       " 'gallat': 271,\n",
       " 'epigallocatechingal': 230,\n",
       " 'inhibit': 318,\n",
       " 'inact': 313,\n",
       " 'epigallocatechin': 229,\n",
       " 'consider': 144,\n",
       " 'cytotox': 168,\n",
       " 'specif': 577,\n",
       " 'structur': 594,\n",
       " 'requir': 531,\n",
       " 'exert': 245,\n",
       " 'inhibitori': 320,\n",
       " 'search': 552,\n",
       " 'cellular': 113,\n",
       " 'bind': 78,\n",
       " 'protein': 506,\n",
       " 'bound': 86,\n",
       " 'clue': 127,\n",
       " 'clarifi': 125,\n",
       " 'mechan': 375,\n",
       " 'interact': 325,\n",
       " 'cellcyclooxygenas': 112,\n",
       " 'inhibitor': 319,\n",
       " 'potenti': 488,\n",
       " 'colon': 131,\n",
       " 'epidemiolog': 227,\n",
       " 'laboratori': 343,\n",
       " 'indic': 314,\n",
       " 'invers': 330,\n",
       " 'risk': 540,\n",
       " 'intak': 324,\n",
       " 'nonsteroid': 421,\n",
       " 'antiinflammatori': 42,\n",
       " 'agent': 21,\n",
       " 'aspirin': 59,\n",
       " 'prostaglandin': 504,\n",
       " 'cyclooxygenas': 166,\n",
       " 'isozym': 333,\n",
       " 'cox': 158,\n",
       " 'overexpress': 437,\n",
       " 'serv': 557,\n",
       " 'sc': 547,\n",
       " 'sulindac': 600,\n",
       " 'control': 150,\n",
       " 'doubleblind': 204,\n",
       " 'azoxymethan': 65,\n",
       " 'aberr': 0,\n",
       " 'crypt': 160,\n",
       " 'foci': 261,\n",
       " 'acf': 9,\n",
       " 'measur': 374,\n",
       " 'efficaci': 211,\n",
       " 'fiveweekold': 260,\n",
       " 'male': 367,\n",
       " 'fed': 259,\n",
       " 'modifi': 396,\n",
       " 'aina': 22,\n",
       " 'ppm': 489,\n",
       " 'placebo': 474,\n",
       " 'later': 345,\n",
       " 'anim': 35,\n",
       " 'except': 244,\n",
       " 'vehicl': 647,\n",
       " 'normal': 422,\n",
       " 'salin': 544,\n",
       " 'inject': 321,\n",
       " 'bodi': 85,\n",
       " 'onc': 431,\n",
       " 'age': 20,\n",
       " 'sacrif': 543,\n",
       " 'expect': 248,\n",
       " 'term': 619,\n",
       " 'focus': 262,\n",
       " 'total': 626,\n",
       " 'format': 263,\n",
       " 'strengthen': 591,\n",
       " 'hypothesi': 306,\n",
       " 'possess': 486,\n",
       " 'against': 18,\n",
       " 'phase': 459,\n",
       " 'sulfonamid': 599,\n",
       " 'discov': 190,\n",
       " 'slowgrow': 573,\n",
       " 'screen': 551,\n",
       " 'model': 395,\n",
       " 'exhibit': 246,\n",
       " 'broad': 89,\n",
       " 'spectrum': 578,\n",
       " 'human': 300,\n",
       " 'xenograft': 657,\n",
       " 'action': 10,\n",
       " 'arrest': 55,\n",
       " 'cycl': 164,\n",
       " 'tubulin': 633,\n",
       " 'polymer': 484,\n",
       " 'object': 427,\n",
       " 'maximum': 372,\n",
       " 'allow': 25,\n",
       " 'dose': 200,\n",
       " 'mad': 364,\n",
       " 'pharmacokinet': 457,\n",
       " 'singl': 569,\n",
       " 'repeat': 527,\n",
       " 'singledos': 570,\n",
       " 'administ': 16,\n",
       " 'oral': 432,\n",
       " 'patient': 444,\n",
       " 'doselimit': 203,\n",
       " 'peripher': 451,\n",
       " 'neuropathi': 413,\n",
       " 'hematolog': 289,\n",
       " 'gastrointestin': 275,\n",
       " 'mild': 389,\n",
       " 'repeateddos': 528,\n",
       " 'per': 449,\n",
       " 'intestin': 327,\n",
       " 'paralysi': 440,\n",
       " 'dosedepend': 202,\n",
       " 'not': 423,\n",
       " 'sever': 559,\n",
       " 'rapid': 517,\n",
       " 'plasma': 477,\n",
       " 'level': 348,\n",
       " 'after': 17,\n",
       " 'disappear': 189,\n",
       " 'variat': 643,\n",
       " 'area': 54,\n",
       " 'concentrationtim': 137,\n",
       " 'curv': 163,\n",
       " 'auc': 63,\n",
       " 'manner': 369,\n",
       " 'recoveri': 522,\n",
       " 'urin': 641,\n",
       " 'favor': 257,\n",
       " 'absorpt': 5,\n",
       " 'elimin': 216,\n",
       " 'profil': 498,\n",
       " 'chang': 120,\n",
       " 'did': 181,\n",
       " 'accumul': 7,\n",
       " 'spinal': 579,\n",
       " 'cord': 153,\n",
       " 'metastasi': 384,\n",
       " 'reduct': 524,\n",
       " 'uterin': 642,\n",
       " 'sarcoma': 546,\n",
       " 'minor': 393,\n",
       " 'mr': 404,\n",
       " 'pulmonari': 511,\n",
       " 'adenocarcinoma': 14,\n",
       " 'decreas': 172,\n",
       " 'carcinoembryon': 99,\n",
       " 'antigen': 41,\n",
       " 'cea': 109,\n",
       " 'squamous': 581,\n",
       " 'scc': 549,\n",
       " 'stomach': 590,\n",
       " 'recurr': 523,\n",
       " 'cervic': 116,\n",
       " 'recommend': 521,\n",
       " 'ii': 311,\n",
       " 'timedepend': 624,\n",
       " 'ie': 310,\n",
       " 'certain': 115,\n",
       " 'growth': 284,\n",
       " 'leukemia': 347,\n",
       " 'conduct': 139,\n",
       " 'schedul': 550,\n",
       " 'maintain': 365,\n",
       " 'blood': 84,\n",
       " 'eretinoid': 235,\n",
       " 'iv': 335,\n",
       " 'design': 176,\n",
       " 'synthesi': 609,\n",
       " 'structureact': 595,\n",
       " 'ditbutylphenyl': 196,\n",
       " 'retino': 535,\n",
       " 'analogu': 29,\n",
       " 'play': 479,\n",
       " 'role': 541,\n",
       " 'differenti': 184,\n",
       " 'apoptosi': 48,\n",
       " 'clinic': 126,\n",
       " 'moieti': 398,\n",
       " 'ditbutylhydroxi': 195,\n",
       " 'phenyl': 461,\n",
       " 'ring': 539,\n",
       " 'seri': 556,\n",
       " 'substitut': 597,\n",
       " 'amid': 28,\n",
       " 'ester': 238,\n",
       " 'synthes': 608,\n",
       " 'mimic': 390,\n",
       " 'molecular': 400,\n",
       " 'shape': 560,\n",
       " 'size': 571,\n",
       " 'spacial': 576,\n",
       " 'disposit': 192,\n",
       " 'general': 276,\n",
       " 'formula': 264,\n",
       " 'see': 554,\n",
       " 'text': 622,\n",
       " 'where': 652,\n",
       " 'stand': 585,\n",
       " 'hydrogen': 301,\n",
       " 'atom': 62,\n",
       " 'methyl': 386,\n",
       " 'linkag': 353,\n",
       " 'conh': 142,\n",
       " 'nhco': 416,\n",
       " 'coo': 152,\n",
       " 'coch': 129,\n",
       " 'ch': 118,\n",
       " 'member': 379,\n",
       " 'heterocycl': 293,\n",
       " 'substitu': 596,\n",
       " 'differ': 183,\n",
       " 'sar': 545,\n",
       " 'presenc': 492,\n",
       " 'hydrophob': 302,\n",
       " 'end': 220,\n",
       " 'molecul': 399,\n",
       " 'carboxyl': 98,\n",
       " 'conjug': 143,\n",
       " 'necessari': 409,\n",
       " 'full': 268,\n",
       " 'prerequisit': 491,\n",
       " 'loss': 357,\n",
       " 'abolish': 3,\n",
       " 'obligatori': 428,\n",
       " 'antioxid': 44,\n",
       " 'hydroxi': 303,\n",
       " 'convey': 151,\n",
       " 'biolog': 79,\n",
       " 'differentiationinduc': 185,\n",
       " 'lose': 356,\n",
       " 'correl': 154,\n",
       " 'stabl': 584,\n",
       " 'conform': 141,\n",
       " 'cisconform': 124,\n",
       " 'nmethyl': 418,\n",
       " 'acyl': 12,\n",
       " 'featur': 258,\n",
       " 'bent': 74,\n",
       " 'instead': 323,\n",
       " 'extend': 251,\n",
       " 'taken': 611,\n",
       " 'nonnmethyl': 419,\n",
       " 'partner': 442,\n",
       " 'alltran': 26,\n",
       " 'account': 6,\n",
       " 'paper': 439,\n",
       " 'signific': 565,\n",
       " 'ditmethoxyphenyl': 197,\n",
       " 'oxopropenyl': 438,\n",
       " 'benzoic': 75,\n",
       " 'compar': 133,\n",
       " 'pharmacolog': 458,\n",
       " 'elicit': 215,\n",
       " 'pleiotrop': 480,\n",
       " 'head': 286,\n",
       " 'neck': 410,\n",
       " 'trihydroxyisoflavon': 631,\n",
       " 'report': 529,\n",
       " 'line': 351,\n",
       " 'vitro': 649,\n",
       " 'varieti': 644,\n",
       " 'upregul': 640,\n",
       " 'pwaf': 512,\n",
       " 'bax': 68,\n",
       " 'downregul': 205,\n",
       " 'cyclin': 165,\n",
       " 'bcl': 69,\n",
       " 'precis': 490,\n",
       " 'still': 589,\n",
       " 'elucid': 218,\n",
       " 'cerbb': 114,\n",
       " 'express': 250,\n",
       " 'mmp': 394,\n",
       " 'secret': 553,\n",
       " 'invas': 329,\n",
       " 'nuclear': 425,\n",
       " 'factorkappab': 254,\n",
       " 'phosphoryl': 466,\n",
       " 'akt': 23,\n",
       " 'moreov': 402,\n",
       " 'telomer': 617,\n",
       " 'shorten': 562,\n",
       " 'telomeras': 618,\n",
       " 'transloc': 630,\n",
       " 'catalyt': 107,\n",
       " 'subunit': 598,\n",
       " 'revers': 537,\n",
       " 'transcriptas': 628,\n",
       " 'htert': 299,\n",
       " 'nucleus': 426,\n",
       " 'result': 534,\n",
       " 'unaffect': 637,\n",
       " 'metaphas': 383,\n",
       " 'spread': 580,\n",
       " 'chromosom': 123,\n",
       " 'togeth': 625,\n",
       " 'publish': 510,\n",
       " 'conclud': 138,\n",
       " 'apoptot': 49,\n",
       " 'death': 170,\n",
       " 'chemotherapeut': 121,\n",
       " 'mechanismbas': 376,\n",
       " 'identif': 309,\n",
       " 'becom': 72,\n",
       " 'issu': 334,\n",
       " 'public': 509,\n",
       " 'healthrel': 287,\n",
       " 'research': 532,\n",
       " 'constitu': 145,\n",
       " 'set': 558,\n",
       " 'up': 639,\n",
       " 'batteri': 67,\n",
       " 'enzymebas': 225,\n",
       " 'relev': 526,\n",
       " 'prevent': 493,\n",
       " 'vivo': 650,\n",
       " 'cypa': 167,\n",
       " 'nadphquinon': 407,\n",
       " 'reductas': 525,\n",
       " 'qr': 513,\n",
       " 'hepacc': 290,\n",
       " 'murin': 406,\n",
       " 'hepatoma': 291,\n",
       " 'scaveng': 548,\n",
       " 'dpph': 207,\n",
       " 'superoxid': 602,\n",
       " 'anion': 36,\n",
       " 'hydroxyl': 305,\n",
       " 'peroxylrad': 453,\n",
       " 'lipopolysaccharid': 354,\n",
       " 'lps': 360,\n",
       " 'mediat': 377,\n",
       " 'nitric': 417,\n",
       " 'generat': 277,\n",
       " 'synthas': 607,\n",
       " 'ino': 322,\n",
       " 'raw': 519,\n",
       " 'macrophag': 363,\n",
       " 'phorbol': 463,\n",
       " 'ornithin': 435,\n",
       " 'decarboxylas': 171,\n",
       " 'odc': 429,\n",
       " 'keratinocyt': 338,\n",
       " 'test': 621,\n",
       " 'known': 341,\n",
       " 'belong': 73,\n",
       " 'organosulfur': 434,\n",
       " 'phenethylisothiocyan': 460,\n",
       " 'peitc': 446,\n",
       " 'diallylsulfid': 180,\n",
       " 'diallyldisulfid': 179,\n",
       " 'terpen': 620,\n",
       " 'limonen': 350,\n",
       " 'perillyl': 450,\n",
       " 'alcohol': 24,\n",
       " 'oleanol': 430,\n",
       " 'betaglycyrrhetin': 77,\n",
       " 'shortchain': 561,\n",
       " 'fatti': 256,\n",
       " 'sodium': 574,\n",
       " 'butyr': 90,\n",
       " 'indol': 315,\n",
       " 'indolecarbinol': 316,\n",
       " 'quercetin': 515,\n",
       " 'silymarin': 566,\n",
       " 'egcg': 212,\n",
       " 'simpl': 567,\n",
       " 'ellag': 217,\n",
       " 'piceatannol': 470,\n",
       " 'curcumin': 162,\n",
       " 'pharmaceut': 456,\n",
       " 'piroxicam': 472,\n",
       " 'acetylsalicyl': 8,\n",
       " 'tamoxifen': 612,\n",
       " 'deriv': 175,\n",
       " 'ascorb': 56,\n",
       " 'trolox': 632,\n",
       " 'confirm': 140,\n",
       " 'demonstr': 173,\n",
       " 'approach': 52,\n",
       " 'hitherto': 296,\n",
       " 'unknown': 638,\n",
       " 'exampl': 243,\n",
       " 'detect': 177,\n",
       " 'nfkappabmedi': 415,\n",
       " 'granulocyt': 282,\n",
       " 'contribut': 149,\n",
       " 'peitcepigallocatechingal': 447,\n",
       " 'her': 292,\n",
       " 'neu': 412,\n",
       " 'downstream': 206,\n",
       " 'signal': 564,\n",
       " 'pathway': 443,\n",
       " 'breast': 88,\n",
       " 'receptor': 520,\n",
       " 'associ': 61,\n",
       " 'poor': 485,\n",
       " 'prognosi': 499,\n",
       " 'hnscc': 297,\n",
       " 'epigalocathechingal': 231,\n",
       " 'compon': 135,\n",
       " 'green': 283,\n",
       " 'tea': 616,\n",
       " 'epiderm': 228,\n",
       " 'egfr': 213,\n",
       " 'therebi': 623,\n",
       " 'egfrrel': 214,\n",
       " 'display': 191,\n",
       " 'constitut': 146,\n",
       " 'microg': 388,\n",
       " 'mark': 371,\n",
       " 'stat': 586,\n",
       " 'cfos': 117,\n",
       " 'bclxl': 70,\n",
       " 'enhanc': 223,\n",
       " 'sensit': 555,\n",
       " 'taxol': 615,\n",
       " 'frequent': 266,\n",
       " 'evid': 242,\n",
       " 'case': 103,\n",
       " 'surviv': 606,\n",
       " 'growthxenoestrogen': 285,\n",
       " 'erk': 236,\n",
       " 'membraneiniti': 381,\n",
       " 'xenoestrogen': 656,\n",
       " 'antagon': 38,\n",
       " 'physiolog': 467,\n",
       " 'estrogen': 241,\n",
       " 'esr': 237,\n",
       " 'er': 233,\n",
       " 'failur': 255,\n",
       " 'assay': 60,\n",
       " 'strong': 592,\n",
       " 'genom': 279,\n",
       " 'estradiol': 240,\n",
       " 'make': 366,\n",
       " 'difficult': 186,\n",
       " 'explain': 249,\n",
       " 'abil': 1,\n",
       " 'abnorm': 2,\n",
       " 'reproduct': 530,\n",
       " 'steroid': 587,\n",
       " 'intracellular': 328,\n",
       " 'calcium': 93,\n",
       " 'camp': 96,\n",
       " 'kinas': 339,\n",
       " 'membran': 380,\n",
       " 'extracellularregul': 252,\n",
       " 'pituitari': 473,\n",
       " 'gh': 280,\n",
       " 'mer': 382,\n",
       " 'phytoestrogen': 469,\n",
       " 'coumestrol': 156,\n",
       " 'organochlorin': 433,\n",
       " 'pesticid': 454,\n",
       " 'endosulfan': 221,\n",
       " 'dieldrin': 182,\n",
       " 'dde': 169,\n",
       " 'deterg': 178,\n",
       " 'byproduct': 91,\n",
       " 'plastic': 478,\n",
       " 'manufactur': 370,\n",
       " 'pnonylphenol': 482,\n",
       " 'bisphenol': 80,\n",
       " 'bisphenola': 81,\n",
       " 'produc': 497,\n",
       " 'min': 392,\n",
       " 'applic': 51,\n",
       " 'depend': 174,\n",
       " 'distinct': 194,\n",
       " 'pattern': 445,\n",
       " 'ca': 92,\n",
       " 'src': 583,\n",
       " 'phosphoinositid': 464,\n",
       " 'disrupt': 193,\n",
       " 'block': 83,\n",
       " 'simultan': 568,\n",
       " 'complex': 134,\n",
       " 'web': 651,\n",
       " 'help': 288,\n",
       " 'low': 358,\n",
       " 'empir': 219,\n",
       " 'appl': 50,\n",
       " 'peroxid': 452,\n",
       " 'gapjunct': 273,\n",
       " 'intercellular': 326,\n",
       " 'communic': 132,\n",
       " 'phytochem': 468,\n",
       " 'content': 147,\n",
       " 'quantifi': 514,\n",
       " 'equival': 232,\n",
       " 'capac': 97,\n",
       " 'vceac': 645,\n",
       " 'estim': 239,\n",
       " 'anitoxid': 37,\n",
       " 'fresh': 267,\n",
       " 'chlorogen': 122,\n",
       " 'phloretin': 462,\n",
       " 'procyanidin': 496,\n",
       " 'carcinogen': 100,\n",
       " 'ho': 298,\n",
       " 'gjic': 281,\n",
       " 'protect': 505,\n",
       " 'strongest': 593,\n",
       " 'divers': 198,\n",
       " 'antioxidlowdos': 45,\n",
       " 'abrog': 4,\n",
       " 'tamoxifenassoci': 613,\n",
       " 'mammari': 368,\n",
       " 'wildtyp': 653,\n",
       " 'erbb': 234,\n",
       " 'transgen': 629,\n",
       " 'mice': 387,\n",
       " 'random': 516,\n",
       " 'implant': 312,\n",
       " 'continuousreleas': 148,\n",
       " 'pellet': 448,\n",
       " 'placebotr': 475,\n",
       " 'soy': 575,\n",
       " 'meal': 373,\n",
       " 'supplement': 603,\n",
       " 'lowdos': 359,\n",
       " 'highdos': 295,\n",
       " 'casein': 104,\n",
       " 'prolong': 501,\n",
       " 'latenc': 344,\n",
       " 'tamoxifentr': 614,\n",
       " 'enrich': 224,\n",
       " 'much': 405,\n",
       " 'rate': 518,\n",
       " 'shorter': 563,\n",
       " 'coadminist': 128,\n",
       " 'prolifer': 500,\n",
       " 'alon': 27,\n",
       " 'summari': 601,\n",
       " 'support': 604,\n",
       " 'doseassoci': 201,\n",
       " 'like': 349,\n",
       " 'new': 414,\n",
       " 'anticanc': 40,\n",
       " 'antimetastat': 43,\n",
       " 'medicin': 378,\n",
       " 'plant': 476,\n",
       " 'review': 538,\n",
       " 'bear': 71,\n",
       " 'metastat': 385,\n",
       " 'drugresist': 208,\n",
       " 'stilben': 588,\n",
       " 'polygonum': 483,\n",
       " 'cassia': 105,\n",
       " 'cassiagrol': 106,\n",
       " 'dimer': 187,\n",
       " 'neovascular': 411,\n",
       " 'tumorbear': 634,\n",
       " 'basidiomycet': 66,\n",
       " 'fungi': 269,\n",
       " 'agaricus': 19,\n",
       " 'blazei': 82,\n",
       " 'ganoderma': 272,\n",
       " 'lucidum': 361,\n",
       " 'celecoxib': 110,\n",
       " 'hypoxia': 307,\n",
       " 'angiopoietin': 33,\n",
       " 'gastric': 274,\n",
       " 'ang': 30,\n",
       " 'augment': 64,\n",
       " 'mimick': 391,\n",
       " 'cocl': 130,\n",
       " 'genestein': 278,\n",
       " 'partial': 441,\n",
       " 'counteract': 157,\n",
       " 'restor': 533,\n",
       " 'exogen': 247,\n",
       " 'pge': 455,\n",
       " 'hypoxiaelev': 308,\n",
       " 'coxderiv': 159,\n",
       " 'hifalpha': 294}"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from sklearn.feature_extraction.text import CountVectorizer\n",
    "textvectorizer = CountVectorizer()\n",
    "textvectorizer.fit(text)\n",
    "textvectorizer.vocabulary_ "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "ae9d61f5",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([[ 2,  2,  1,  1,  2,  1,  1,  1,  1,  5,  9, 45,  1,  4,  1,  3,\n",
       "         2,  5,  4,  1,  3, 11,  1,  1,  1,  1,  1,  1,  2,  1,  7,  3,\n",
       "         1,  2,  2,  3,  2,  1,  1,  1,  2,  2,  4,  4,  9,  1,  8,  5,\n",
       "         3,  1,  8,  1,  1,  1,  1,  3,  1,  1,  1,  1,  3,  4,  1,  1,\n",
       "         1,  2,  2,  1,  1,  1,  1,  1,  1,  1,  2,  1,  1,  1,  3,  2,\n",
       "         1,  1,  1,  1,  1,  1,  1,  1,  6,  1,  1,  1,  1,  1,  1,  1,\n",
       "         1,  3,  1,  1,  1,  2, 12,  1,  2,  1,  1,  1,  6,  1,  3, 44,\n",
       "         1,  2,  1,  1,  1,  1,  1,  9,  4,  1,  2,  1,  1,  1,  1,  1,\n",
       "         1,  1,  1,  9,  2,  2,  1,  1,  9,  1,  1,  1,  2,  3,  1,  1,\n",
       "         1,  1,  1,  1,  1,  3,  2,  1,  1,  1,  1,  1,  1,  2, 10,  1,\n",
       "         5,  3,  1,  1,  3,  3,  3,  1,  1,  1,  1,  1,  2,  2,  1,  4,\n",
       "         2,  1,  1,  1,  1,  1,  1,  3,  2,  1,  1,  1,  1,  1,  1,  2,\n",
       "         1,  2,  2,  1,  1,  1,  1,  1, 12,  1,  4,  2,  1,  4,  2,  1,\n",
       "         1,  1, 17,  1,  8,  3,  1,  3,  1,  1,  1,  3,  2,  1,  3,  1,\n",
       "         2,  1,  4,  1,  2,  1,  2,  1,  1,  2,  1,  1,  6,  2,  3,  1,\n",
       "         1,  1,  1,  1,  2,  2,  4,  1,  1,  2, 10,  1,  1,  3,  1,  1,\n",
       "         1,  1,  1,  3,  1,  1,  1,  2,  2,  1,  1,  1,  1,  1,  3,  1,\n",
       "         1,  2,  3,  2,  1,  2,  1,  1,  1,  3,  1,  2, 11,  1,  8,  1,\n",
       "         1,  2,  1,  1,  7,  1,  1,  2,  1,  6,  3,  1,  8,  3,  1,  2,\n",
       "         1,  1,  1,  7,  1,  4,  1,  2,  1,  2,  6,  1,  1, 22, 37,  8,\n",
       "         3,  1,  1,  1,  1,  5,  2,  1,  2,  1,  1,  4,  5,  1,  1,  1,\n",
       "         1,  3,  1,  3,  1,  2,  1,  1,  3,  1,  1,  1,  7,  1,  1, 10,\n",
       "         1,  1,  1,  2,  1,  1,  3,  3,  1,  1,  4,  1,  1,  1,  1,  1,\n",
       "         5,  2,  1,  2,  1,  2,  1, 11,  1,  2,  2,  1,  3,  1,  1,  1,\n",
       "         4,  1,  2,  8,  2,  1,  2,  1,  1,  1,  2,  4,  1,  3,  1,  3,\n",
       "         6,  1,  1,  6,  1,  1,  3,  1,  1,  1,  8,  3,  3,  2,  2,  1,\n",
       "         1,  2,  1,  1,  1,  2,  1,  6,  3,  1,  1,  1,  1,  2,  1,  1,\n",
       "         2,  1,  1,  1,  2,  2,  1,  1,  1,  2,  1,  7,  9,  1,  3,  1,\n",
       "         1,  2,  1,  2,  2,  1,  1,  2,  1,  2,  1,  5,  1,  2,  2,  2,\n",
       "         1,  1,  3,  1,  1,  3,  1,  1,  1,  1,  2,  1,  2,  4,  1,  2,\n",
       "         2,  1,  1,  1,  1,  1,  1,  1,  6,  4,  1,  1,  1,  4,  1,  1,\n",
       "         2,  1,  1,  1,  1,  2,  5,  4,  1,  2,  3,  1,  1,  1,  1,  1,\n",
       "         1,  1,  1,  3,  1,  4,  1,  1,  5,  2,  1,  1,  1,  1,  2,  1,\n",
       "         4,  5,  2,  2,  1,  1,  7,  4,  2,  3,  1,  2,  1,  2,  2,  1,\n",
       "         1,  1,  1,  6,  4,  1,  1,  2,  2,  1,  1,  1,  2,  1,  1,  1,\n",
       "         2,  1,  2,  1,  7,  1,  1,  1,  1,  2,  4,  1,  1,  1,  1,  2,\n",
       "         1,  3,  1,  1,  1,  2,  1,  1,  1,  1,  1,  1,  3,  1,  1,  1,\n",
       "         1,  1,  4,  1,  1,  1,  1,  1,  3,  1,  4,  1,  1,  6,  1,  1,\n",
       "         1,  1,  4,  2,  7,  2,  2,  1,  2,  2,  4,  1,  1,  2,  1,  1,\n",
       "         1,  2,  4,  2,  1,  1,  1,  1,  1,  1,  1,  2,  1,  1,  1,  1,\n",
       "         2,  1,  2,  1,  2,  2,  1,  1,  4,  9,  6,  1,  1,  1,  1,  1,\n",
       "         7,  1]], dtype=int64)"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "textvectorizer.transform(text).toarray()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "0698abc3",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>abstract</th>\n",
       "      <th>classe</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>antitumorpromot principl angelica keiskei pote...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>effect catechin mous lung carcinoma cell adhes...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>cyclooxygenas inhibitor potenti properti colon...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>phase novel sulfonamid discov slowgrow colon c...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>retinoid iv design synthesi structureact ditbu...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                            abstract  classe\n",
       "0  antitumorpromot principl angelica keiskei pote...       1\n",
       "1  effect catechin mous lung carcinoma cell adhes...       1\n",
       "2  cyclooxygenas inhibitor potenti properti colon...       1\n",
       "3  phase novel sulfonamid discov slowgrow colon c...       1\n",
       "4  retinoid iv design synthesi structureact ditbu...       1"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#reading the data\n",
    "data = pd.read_csv(\"Corpus_processado2.csv\",encoding=\"latin-1\", sep=';')\n",
    "data.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "774afd01",
   "metadata": {},
   "outputs": [],
   "source": [
    "from sklearn.model_selection import train_test_split\n",
    "review = data['abstract'].values\n",
    "label = data['classe'].values\n",
    "review_train, review_test, label_train, label_test = train_test_split(\n",
    "review, label, test_size=0.25, random_state=1000) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "11aef557",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<299x5803 sparse matrix of type '<class 'numpy.int64'>'\n",
       "\twith 20604 stored elements in Compressed Sparse Row format>"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from sklearn.feature_extraction.text import CountVectorizer\n",
    "review_vectorizer = CountVectorizer()\n",
    "review_vectorizer.fit(review_train)\n",
    "Xlr_train = review_vectorizer.transform(review_train)\n",
    "Xlr_test  = review_vectorizer.transform(review_test) \n",
    "Xlr_train"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "b21858ac",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Accuracy: 0.97\n"
     ]
    }
   ],
   "source": [
    "from sklearn.linear_model import LogisticRegression\n",
    "LRmodel = LogisticRegression()\n",
    "LRmodel.fit(Xlr_train, label_train)\n",
    "score = LRmodel.score(Xlr_test, label_test)\n",
    "print(\"Accuracy:\", score) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "ec26ab88",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "periop anesthesia care narrat review discuss uptod focus avail best clinic practic periop anesthesia care bundl effect main object apprais literatur local anesthet region outcom opioid nonsteroid antiinflammatori nsaid abil decreas recurr patient undergo surgeri brief discuss addit topic periop relev anesthesiologist volatil intraven anesthet periop anxieti nutrit result publish systemat review look associ recurr region anesthesia yield inconclus insuffici evid definit benefit region anesthesia basic scienc anti effect induc local anesthet new refin anim model opioid safe periop pain manag preliminari evid nsaid essenti multimod analgesia volatil anesthet format preclin clinic propofol indic protect qualiti periop period patient uniqu environ where surgic mediat lead suppress region anesthesia techniqu indic multimod analgesia nsaid opioid local anesthet prevent pathophysiolog effect pain neuroendocrin view essenti balanc anesthesia\n",
      "[702, 128, 504, 2332, 92, 284, 2333, 503, 206, 636, 85, 909, 702, 128, 504, 2334, 3, 225, 910, 2335, 703, 377, 207, 199, 251, 1250, 285, 68, 121, 234, 28, 103, 9, 436, 113, 1821, 284, 55, 3338, 702, 326, 3339, 1475, 704, 207, 702, 3340, 505, 10, 1052, 564, 92, 2336, 15, 103, 199, 128, 566, 2337, 1822, 45, 1823, 235, 199, 128, 1251, 1824, 2338, 3, 4, 377, 207, 96, 3341, 208, 97, 1250, 637, 702, 1252, 808, 1053, 45, 121, 809, 2339, 1054, 1475, 207, 236, 506, 85, 107, 44, 161, 1055, 702, 269, 9, 705, 908, 378, 327, 147, 116, 46, 199, 128, 69, 44, 2339, 1054, 121, 1250, 377, 207, 65, 3342, 3, 1252, 2340, 1476, 809, 1477, 128]\n"
     ]
    }
   ],
   "source": [
    "from keras.preprocessing.text import Tokenizer\n",
    "tokenizer = Tokenizer(num_words=5000)\n",
    "tokenizer.fit_on_texts(review_train)\n",
    "Xcnn_train = tokenizer.texts_to_sequences(review_train)\n",
    "Xcnn_test = tokenizer.texts_to_sequences(review_test)\n",
    "vocab_size = len(tokenizer.word_index) + 1  \n",
    "print(review_train[1])\n",
    "print(Xcnn_train[1]) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "be836ee7",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[ 189  564   92  565  907 1471   53    2    7  299 1248  908  375   53\n",
      "    7 1471 3334   65  146   43  283   11  223   13  435  221  102 2330\n",
      "  223 2329 1472   93 1818 1473  564   92  565    3 1472  102   20 2331\n",
      "    1  138   41 3335  701 1249 3336   53   83  160    1  189    1   12\n",
      "    3 1050 1819 1051  181  153    3 1472  189    1 1819  325  351  503\n",
      "  376  102 1819  325  351    3  283   11 1472  102    3 2331    1 1049\n",
      "  222   53    7  166  907  131  268 1820   19   84  635  462  352 3337\n",
      " 1474  224]\n"
     ]
    }
   ],
   "source": [
    "from keras.preprocessing.sequence import pad_sequences\n",
    "maxlen = 100\n",
    "Xcnn_train = pad_sequences(Xcnn_train, padding='post', maxlen=maxlen)\n",
    "Xcnn_test = pad_sequences(Xcnn_test, padding='post', maxlen=maxlen)\n",
    "print(Xcnn_train[0, :]) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "bd2c099c",
   "metadata": {},
   "outputs": [],
   "source": [
    "from keras.models import Sequential\n",
    "from keras import layers "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "ae6197b1",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Model: \"sequential\"\n",
      "_________________________________________________________________\n",
      " Layer (type)                Output Shape              Param #   \n",
      "=================================================================\n",
      " embedding (Embedding)       (None, 100, 200)          1161400   \n",
      "                                                                 \n",
      " conv1d (Conv1D)             (None, 96, 128)           128128    \n",
      "                                                                 \n",
      " global_max_pooling1d (Globa  (None, 128)              0         \n",
      " lMaxPooling1D)                                                  \n",
      "                                                                 \n",
      " dense (Dense)               (None, 10)                1290      \n",
      "                                                                 \n",
      " dense_1 (Dense)             (None, 1)                 11        \n",
      "                                                                 \n",
      "=================================================================\n",
      "Total params: 1,290,829\n",
      "Trainable params: 1,290,829\n",
      "Non-trainable params: 0\n",
      "_________________________________________________________________\n"
     ]
    }
   ],
   "source": [
    "embedding_dim = 200\n",
    "textcnnmodel = Sequential()\n",
    "textcnnmodel.add(layers.Embedding(vocab_size, embedding_dim, input_length=maxlen))\n",
    "textcnnmodel.add(layers.Conv1D(128, 5, activation='relu'))\n",
    "textcnnmodel.add(layers.GlobalMaxPooling1D())\n",
    "textcnnmodel.add(layers.Dense(10, activation='relu'))\n",
    "textcnnmodel.add(layers.Dense(1, activation='sigmoid'))\n",
    "textcnnmodel.compile(optimizer='adam',\n",
    "               loss='binary_crossentropy',\n",
    "               metrics=['accuracy'])\n",
    "textcnnmodel.summary() "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "25648be1",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Training Accuracy: 1.0000\n",
      "Testing Accuracy:  0.9600\n"
     ]
    }
   ],
   "source": [
    "textcnnmodel.fit(Xcnn_train, label_train,\n",
    "                     epochs=10,\n",
    "                     verbose=False,\n",
    "                     validation_data=(Xcnn_test, label_test),\n",
    "                     batch_size=10)\n",
    "loss, accuracy = textcnnmodel.evaluate(Xcnn_train, label_train, verbose=False)\n",
    "print(\"Training Accuracy: {:.4f}\".format(accuracy))\n",
    "loss, accuracy = textcnnmodel.evaluate(Xcnn_test, label_test, verbose=False)\n",
    "print(\"Testing Accuracy:  {:.4f}\".format(accuracy)) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "bb450e1a",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.8"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
